Cyclic octapeptide somatostatin analog (Ki
values are 0.7, 5.4, 30.9, 45 and > 1000 nM for sst5
receptors respectively). More metabolically stable than somatostatin
(Cat. No. 1157). Inhibits growth hormone release in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
Karashima et al.
Life Sci., 1987;41:1011
Subtype selectivity of peptide analogs for all five coned human somatostatin receptors (hsstr 1-5).
Patel and Srikant
sst2 Somatostatin receptor inhibits cell proliferation through Ras- Rap1-, and B-raf-dependent ERK2 activation.
Lahlou et al.